文献速递神经免疫认知障碍与痴呆

从影像学视角诊断进展型多发性硬化:综述

Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review.
PubMed 文献 · JAMA Neurol · 2021-01-01

本综述探讨MRI在进展型多发性硬化诊断与预后中的应用,指出脊髓弥漫性异常及累及灰质和≥2个白质柱的病变对原发进展型MS有提示意义,关键中枢区域病变位置和诊断早期高炎症活动是长期残疾和进展型病程的危险因素,目前尚无定性特征区分原发进展型与继发进展型MS。

要点

  • 脊髓弥漫性异常及累及灰质和≥2个白质柱的病变提示原发进展型MS。
  • 关键中枢区域病变位置和诊断早期高炎症活动预示长期残疾与进展型病程。
  • 尚无定性临床、免疫、病理或影像特征区分原发进展型与继发进展型MS。

核心结论

  • 原发进展型MS的诊断比复发缓解型MS更具挑战性,尚无定性特征区分原发进展型与继发进展型MS。
  • 识别能区分原发进展型与复发缓解型MS及预测复发缓解型向继发进展型演变的新型MRI标志物是未满足的诊断需求。

研究设计与样本

  • 综述类文章,检索范围未在原文摘要中报告。

主要发现

  • 脊髓弥漫性异常及累及灰质和≥2个白质柱的病变对原发进展型MS有提示意义但非特异。
  • 原发进展型MS和复发起病型MS患者中,关键中枢神经系统区域(脊髓、幕下区域和灰质)的病变位置及诊断后最初数年MRI检测到的高炎症活动是长期残疾和未来进展型病程的危险因素。
  • 已确诊MS患者中,灰质受累和神经退行性变与临床恶化加速相关。
  • 亚软膜脱髓鞘和缓慢扩大病变是进展型MS的新型指标。

临床怎么用

  • 上述影像学指标可在临床实践中评估,用于原发进展型MS的诊断提示和进展型病程的风险评估。
  • 整合多参数可能对实现区分原发进展型与复发缓解型MS及预测复发缓解型向继发进展型演变是必要的。

局限性

  • 原发进展型MS的脊髓影像特征非特异。
  • 尚无定性临床、免疫、病理或影像特征区分原发进展型与继发进展型MS。
  • 进展型MS的影像表现受衰老和合并症影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Although magnetic resonance imaging (MRI) is useful for monitoring disease dissemination in space and over time and excluding multiple sclerosis (MS) mimics, there has been less application of MRI to progressive MS, including diagnosing primary progressive (PP) MS and identifying patients with relapsing-remitting (RR) MS who are at risk of developing secondary progressive (SP) MS. This review addresses clinical application of MRI for both diagnosis and prognosis of progressive MS. OBSERVATIONS: Although nonspecific, some spinal cord imaging features (diffuse abnormalities and lesions involving gray matter [GM] and ≥2 white matter columns) are typical of PPMS. In patients with PPMS and those with relapse-onset MS, location of lesions in critical central nervous system regions (spinal cord, infratentorial regions, and GM) and MRI-detected high inflammatory activity in the first years after diagnosis are risk factors for long-term disability and future progressive disease course. These measures are evaluable in clinical practice. In patients with established MS, GM involvement and neurodegeneration are associated with accelerated clinical worsening. Subpial demyelination and slowly expanding lesions are novel indicators of progressive MS. CONCLUSIONS AND RELEVANCE: Diagnosis of PPMS is more challenging than diagnosis of RRMS. No qualitative clinical, immunological, histopathological, or neuroimaging features differentiate PPMS and SPMS; both are characterized by imaging findings reflecting neurodegeneration and are also impacted by aging and comorbidities. Unmet diagnostic needs include identification of MRI markers capable of distinguishing PPMS from RRMS and predicting the evolution of RRMS to SPMS. Integration of multiple parameters will likely be essential to achieve these aims.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Filippi M, Preziosa P, Barkhof F, et al. Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review. JAMA Neurol. 2021. PMID: 33315071. doi:10.1001/jamaneurol.2020.4689

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。